See also this year's filing and all EDGAR filings for this company.
PDF Report 0001042074_2023_CymaBay_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001042074, CymaBay Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 138,073,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 701,000 |
| 3 | remainder_Assets | 3,078,000 |
| 4 | LiabilitiesCurrent | 15,441,000 |
| 5 | LiabilitiesNoncurrent | 30,000 |
| 6 | remainder_Liabilities | 90,227,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,116,000 |
| 9 | ResearchAndDevelopmentExpense | 67,995,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -12,890,000 |
| 13 | remainder_ComprehensiveNetIncome | -313,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 141,852,000 |
| 1 | Liabilities | 105,698,000 |
| 2 | Expenses | 93,111,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 36,154,000 |
| 5 | NetIncome | -106,001,000 |
| 6 | ComprehensiveNetIncome | -106,157,500 |
| 7 | BaseVar | 176,932,000 |
| 8 | EconomicCapitalRatio | -0.355 |
Edgar->Model Mapping
Feature Distribution
Change over Time
